NASDAQ : HLVX
-$0.01 (-0.48%)
15
24
$8.93M
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 2025-09-17 | U-Tender | 1.95 | 2025-09-19 |
| Frazier Life Sciences X, L.P. | 10 percent owner | 2025-09-17 | U-Tender | 1.95 | 2025-09-17 |
| HERSHBERG ROBERT | director, officer: President and CEO | 2025-09-17 | U-Tender | 1.95 | 2025-09-17 |
| Cocero Nanette | director | 2025-09-17 | U-Tender | 1.95 | 2025-09-17 |
| HILLEMAN JERYL L | director | 2025-09-17 | U-Tender | 1.95 | 2025-09-17 |
| Chu Shelley | director | 2025-09-17 | U-Tender | 1.95 | 2025-09-17 |
| Dubin Gary | director | 2025-09-17 | U-Tender | 1.95 | 2025-09-17 |
| Kohli Aditya | director | 2025-09-17 | U-Tender | 1.95 | 2025-09-17 |
| Gerberding Julie L. | director | 2025-09-17 | U-Tender | 1.95 | 2025-09-17 |
| Maltbie Shane | officer: Chief Financial Officer | 2025-09-17 | U-Tender | 1.95 | 2025-09-17 |
| Sepulveda Jaime | director | 2025-09-17 | U-Tender | 1.95 | 2025-09-17 |
| Heron Patrick J | director | 2025-06-23 | A-Award | 0 | 2025-06-25 |
| Kohli Aditya | director | 2025-06-23 | A-Award | 0 | 2025-06-25 |
| Chu Shelley | director | 2025-06-23 | A-Award | 0 | 2025-06-25 |
| Sepulveda Jaime | director | 2025-06-23 | A-Award | 0 | 2025-06-25 |
| Cocero Nanette | director | 2025-06-23 | A-Award | 0 | 2025-06-25 |
| Gerberding Julie L. | director | 2025-06-23 | A-Award | 0 | 2025-06-25 |
| Dubin Gary | director | 2025-06-23 | A-Award | 0 | 2025-06-25 |
| HILLEMAN JERYL L | director | 2025-06-23 | A-Award | 0 | 2025-06-25 |
| Chu Shelley | director | 2024-06-06 | A-Award | 13.75 | 2025-04-30 |
| Cocero Nanette | director | 2024-06-06 | A-Award | 13.75 | 2025-04-30 |
| Gerberding Julie L. | director | 2024-06-06 | A-Award | 13.75 | 2025-04-30 |
| HILLEMAN JERYL L | director | 2024-06-06 | A-Award | 13.75 | 2025-04-30 |
| Sepulveda Jaime | director | 2024-06-06 | A-Award | 13.75 | 2025-04-30 |
| Heron Patrick J | director | 2024-06-06 | A-Award | 13.75 | 2025-04-30 |
| HERSHBERG ROBERT | director, officer: See Remarks | 2025-02-04 | S-Sale | 1.89 | 2025-02-12 |
| HERSHBERG ROBERT | director, officer: See Remarks | 2025-02-11 | S-Sale | 1.7648 | 2025-02-12 |
| Maltbie Shane | officer: Chief Financial Officer | 2025-02-04 | S-Sale | 1.89 | 2025-02-12 |
| Maltbie Shane | officer: Chief Financial Officer | 2025-02-11 | S-Sale | 1.7627 | 2025-02-12 |
| Frazier Life Sciences X, L.P. | 2024-04-04 | 0 | 2024-05-31 | ||
| Kohli Aditya | director | 2024-05-20 | S-Sale | 15.4482 | 2024-05-22 |
| Kohli Aditya | director | 2024-05-21 | S-Sale | 14.205 | 2024-05-22 |
| Kohli Aditya | director | 2024-05-22 | S-Sale | 14.7287 | 2024-05-22 |
| Kohli Aditya | director | 2024-05-01 | S-Sale | 14.0343 | 2024-05-03 |
| Kohli Aditya | director | 2024-05-02 | S-Sale | 14.0135 | 2024-05-03 |
| Kohli Aditya | director | 2024-05-03 | S-Sale | 14.1542 | 2024-05-03 |
| Frazier Life Sciences X, L.P. | 10 percent owner | 2024-04-04 | P-Purchase | 14.5 | 2024-04-08 |
| Kohli Aditya | director | 2024-04-03 | S-Sale | 14.9303 | 2024-04-05 |
| Kohli Aditya | director | 2024-04-04 | S-Sale | 14.7075 | 2024-04-05 |
| Kohli Aditya | director | 2024-04-05 | S-Sale | 14.44 | 2024-04-05 |
| McLoughlin Sean | officer: Chief Operating Officer | 2024-03-28 | P-Purchase | 16.98 | 2024-04-01 |
| Kohli Aditya | director | 2024-03-18 | S-Sale | 17.6561 | 2024-03-20 |
| Kohli Aditya | director | 2024-03-19 | S-Sale | 17.4153 | 2024-03-20 |
| Kohli Aditya | director | 2024-03-20 | S-Sale | 164221 | 2024-03-20 |
| Kohli Aditya | director | 2024-03-06 | S-Sale | 18.9501 | 2024-03-08 |
| Kohli Aditya | director | 2024-03-07 | S-Sale | 18.3688 | 2024-03-08 |
| Kohli Aditya | director | 2024-03-08 | S-Sale | 18.6598 | 2024-03-08 |
| Kohli Aditya | director | 2024-02-20 | S-Sale | 14.8786 | 2024-02-22 |
| Kohli Aditya | director | 2024-02-21 | S-Sale | 14.9158 | 2024-02-22 |
| Kohli Aditya | director | 2024-02-22 | S-Sale | 15.052 | 2024-02-22 |
| Kohli Aditya | director | 2024-02-12 | S-Sale | 15.3201 | 2024-02-14 |
| Kohli Aditya | director | 2024-02-08 | A-Award | 0 | 2024-02-12 |
| Kohli Aditya | director | 2024-02-08 | S-Sale | 14.9315 | 2024-02-12 |
| Kohli Aditya | director | 2024-02-08 | A-Award | 15.06 | 2024-02-12 |
| Maltbie Shane | officer: Chief Financial Officer | 2024-02-08 | A-Award | 0 | 2024-02-12 |
| Maltbie Shane | officer: Chief Financial Officer | 2024-02-08 | A-Award | 15.06 | 2024-02-12 |
| Maltbie Shane | officer: Chief Financial Officer | 2024-02-08 | S-Sale | 14.9315 | 2024-02-12 |
| HERSHBERG ROBERT | director, officer: See Remarks | 2024-02-08 | A-Award | 0 | 2024-02-12 |
| HERSHBERG ROBERT | director, officer: See Remarks | 2024-02-08 | S-Sale | 14.9315 | 2024-02-12 |
| HERSHBERG ROBERT | director, officer: See Remarks | 2024-02-08 | A-Award | 15.06 | 2024-02-12 |
| Borkowski Astrid | officer: Chief Medical Officer | 2024-02-08 | A-Award | 0 | 2024-02-12 |
| Borkowski Astrid | officer: Chief Medical Officer | 2024-02-08 | S-Sale | 14.9315 | 2024-02-12 |
| Borkowski Astrid | officer: Chief Medical Officer | 2024-02-08 | A-Award | 15.06 | 2024-02-12 |
| McLoughlin Sean | officer: Chief Operating Officer | 2024-01-31 | A-Award | 14.17 | 2024-02-02 |
| McLoughlin Sean | 2023-01-16 | 0 | 2024-01-26 | ||
| Borkowski Astrid | officer: Chief Medical Officer | 2023-12-15 | S-Sale | 15.5 | 2023-12-18 |
| Borkowski Astrid | officer: Chief Medical Officer | 2023-12-01 | S-Sale | 14.2 | 2023-12-05 |
| Borkowski Astrid | officer: Chief Medical Officer | 2023-12-04 | S-Sale | 14.5 | 2023-12-05 |
| Borkowski Astrid | officer: Chief Medical Officer | 2023-11-17 | S-Sale | 14 | 2023-11-20 |
| Borkowski Astrid | officer: Chief Medical Officer | 2023-11-08 | S-Sale | 13 | 2023-11-13 |
| Borkowski Astrid | officer: Chief Medical Officer | 2023-06-21 | D-Return | 16.11 | 2023-06-23 |
| Chu Shelley | director | 2023-06-07 | A-Award | 17.94 | 2023-06-09 |
| Cocero Nanette | director | 2023-06-07 | A-Award | 17.94 | 2023-06-09 |
| Gerberding Julie L. | director | 2023-06-07 | A-Award | 17.94 | 2023-06-09 |
| Sepulveda Jaime | director | 2023-06-07 | A-Award | 17.94 | 2023-06-09 |
| HILLEMAN JERYL L | director | 2023-06-07 | A-Award | 17.94 | 2023-06-09 |
| Heron Patrick J | director, 10 percent owner: | 2023-06-07 | A-Award | 17.94 | 2023-06-09 |
| Cocero Nanette | director | 2023-05-08 | A-Award | 14.2 | 2023-05-10 |
| Cocero Nanette | director: | 2023-05-08 | 0 | 2023-05-10 | |
| Borkowski Astrid | officer: Chief Medical Officer | 2023-02-01 | A-Award | 0 | 2023-02-03 |
| Borkowski Astrid | officer: Chief Medical Officer | 2023-02-01 | A-Award | 18 | 2023-02-03 |
| Kohli Aditya | director, officer: Chief Operating Officer | 2023-02-01 | A-Award | 0 | 2023-02-03 |
| Kohli Aditya | director, officer: Chief Operating Officer | 2023-02-01 | A-Award | 18 | 2023-02-03 |
| HERSHBERG ROBERT | director, officer: President and CEO | 2023-02-01 | A-Award | 0 | 2023-02-03 |
| HERSHBERG ROBERT | director, officer: President and CEO | 2023-02-01 | A-Award | 18 | 2023-02-03 |
| Maltbie Shane | officer: Chief Financial Officer | 2023-02-01 | A-Award | 18 | 2023-02-03 |
| Maltbie Shane | officer: Chief Financial Officer | 2023-02-01 | A-Award | 0 | 2023-02-03 |
| Maltbie Shane | officer: Chief Financial Officer | 2023-01-06 | 8.05 | 2023-01-10 | |
| Maltbie Shane | officer: Chief Financial Officer | 2023-01-06 | 0 | 2023-01-10 | |
| TAKEDA PHARMACEUTICAL CO LTD | director | 2022-11-30 | X-InTheMoney | 0 | 2022-12-01 |
| TAKEDA PHARMACEUTICAL CO LTD | director | 2022-11-30 | X-InTheMoney | 0 | 2022-12-01 |
| Gerberding Julie L. | director | 2022-08-19 | A-Award | 12.38 | 2022-08-23 |
| Gerberding Julie L. | director: | 2022-08-19 | A-Award | 0 | 2022-08-23 |
| Silbermann Susan Michele | director: | 2022-08-19 | A-Award | 0 | 2022-08-23 |
| Chu Shelley | director: | 2022-08-19 | A-Award | 0 | 2022-08-23 |
| HILLEMAN JERYL L | director | 2022-08-19 | A-Award | 12.38 | 2022-08-23 |
| HILLEMAN JERYL L | director: | 2022-08-19 | A-Award | 0 | 2022-08-23 |
| Sepulveda Jaime | director: | 2022-08-19 | A-Award | 0 | 2022-08-23 |
| Heron Patrick J | director: | 2022-08-19 | A-Award | 0 | 2022-08-23 |
| Heron Patrick J | director, 10 percent owner: | 2022-08-19 | A-Award | 12.38 | 2022-08-23 |